Aroa Biosurgery Limited (ASX:ARX)

Aroa Biosurgery Ratios and Metrics

Market cap in millions AUD. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 6, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	185	206	147	191	360	265
Market Cap Growth	-19.95%	40.23%	-23.27%	-46.97%	35.74%	-26.45%
Enterprise Value	168	191	133	165	321	207
Last Close Price	0.54	0.59	0.42	0.56	1.05	0.78

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 6, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	49.82	52.78	-	-	-	-
Forward PE	42.46	42.79	37.72	114.28	-	-
PS Ratio	2.14	2.38	1.91	3.02	6.09	7.22
PB Ratio	2.24	2.49	1.73	2.19	3.79	2.85
P/TBV Ratio	2.59	2.87	2.06	2.63	4.51	3.44
P/FCF Ratio	23.55	26.16	-	-	-	-
P/OCF Ratio	21.08	23.41	-	-	-	-

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 6, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	1.94	2.21	1.73	2.60	5.43	5.65
EV/EBITDA Ratio	19.78	25.96	573.12	-	-	-
EV/EBIT Ratio	35.48	40.39	-	-	-	-
EV/FCF Ratio	21.35	24.31	-	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 6, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.06	0.06	0.07	0.08	0.07	0.06
Debt / EBITDA Ratio	0.63	0.63	4.74	-	9.83	-
Debt / FCF Ratio	0.68	0.68	-	-	-	-
Net Debt / Equity Ratio	-0.21	-0.21	-0.17	-0.24	-0.38	-0.51
Net Debt / EBITDA Ratio	-2.35	-2.35	-61.70	3.08	462.23	9.75
Net Debt / FCF Ratio	-2.20	-2.20	3.23	2.09	3.96	3.23
Asset Turnover	0.91	0.91	0.77	0.61	0.55	0.41
Inventory Turnover	2.10	2.10	1.48	1.56	2.24	2.47
Quick Ratio	4.18	4.18	5.46	6.21	9.06	11.11
Current Ratio	4.77	4.77	6.49	7.26	9.88	11.90
Return on Equity (ROE)	4.86%	4.86%	-4.06%	-10.80%	-0.39%	-10.55%
Return on Assets (ROA)	3.09%	3.09%	-1.66%	-5.86%	-1.70%	-4.97%
Return on Invested Capital (ROIC)	6.41%	6.46%	-3.90%	-15.78%	-5.55%	-17.63%
Return on Capital Employed (ROCE)	5.40%	5.40%	-3.00%	-10.50%	-2.90%	-7.20%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 6, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	2.10%	1.90%	-2.36%	-5.10%	-0.10%	-2.93%
FCF Yield	4.25%	3.82%	-3.02%	-5.23%	-2.54%	-5.57%
Buyback Yield / Dilution	-5.39%	-5.39%	-0.31%	-0.27%	-0.22%	-13.90%

Data Source: S&P Global Market Intelligence Last updated: May 25, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 2, 2026

Data Sources Report a data error